Women in Healthy Transition (KISO) Survey Cohort: Exploring menopausal symptoms in Denmark

Abstract Background Menopause eventually affects all women, with menopausal symptoms varying significantly across the globe. In Denmark, there is an important data gap in understanding women's symptoms and how they affect women. To address this, we developed the nationwide Women in Healthy Transition (KISO) Survey Cohort to explore symptoms through different stages of menopause. Methods The KISO Survey targeted 575,863 women aged 45-59 living in Denmark. Data was collected via digital questionnaires from June to December 2024, covering stages of menopause based on STRAW + 10, menopausal symptoms using MRS, quality of life using UQOL, physical activity measured with IPAQ, work productivity loss based on WPAI, and various health, social and lifestyle factors. Statistical analyses were performed to assess symptom prevalence and severity across stages of menopause. Results A total of 153,800 women participated in the study (27% response rate), with 8% in premenopause, 24% in perimenopause, and 45% in postmenopause. Additionally, 13% had induced menopause and 10% were on menopausal hormone therapy (MHT). Symptom prevalence and severity increased notably from premenopause to perimenopause and continued to be present through postmenopausal phases. Women in early postmenopause (1-2 years) reported the highest total symptom burden with 24% experiencing severe symptoms, compared with women in other menopausal phases. While women with induced menopause and on MHT reported an even higher prevalence of severe symptoms (31% and 38%, respectively). Urogenital symptoms were the most severe symptom domain across all stages, peaking among women in late early postmenopause (>2-8 years), with 38% reporting these symptoms as severe. Implications This is the first study to provide large-scale data on menopausal symptoms among women in Denmark. The KISO Survey Cohort offers unique and extensive data, enabling future studies to advance our understanding of menopause and its impact on women. Key messages • Women in early postmenopause report the highest menopausal symptom burden, with 24% experiencing severe symptoms. • The KISO Survey Cohort offers unique data to advance our understanding of menopause.

Authors

Institutions

Publication Details

Journal
European Journal of Public Health
Published
2025-10-01
DOI
https://doi.org/10.1093/eurpub/ckaf161.412
Primary Topic
Sex and Gender in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Women in Healthy Transition (KISO) Survey Cohort: Exploring menopausal symptoms in Denmark

Torben Jørgensen, Maria Gliemann Hybholt, Sigrid Normann Biener
European Journal of Public Health
Sex and Gender in Healthcare
article

Women in Healthy Transition (KISO) Survey Cohort: Exploring menopausal symptoms in Denmark

Torben Jørgensen, Maria Gliemann Hybholt, Sigrid Normann Biener
article en

Abstract

Abstract Background Menopause eventually affects all women, with menopausal symptoms varying significantly across the globe. In Denmark, there is an important data gap in understanding women's symptoms and how they affect women. To address this, we developed the nationwide Women in Healthy Transition (KISO) Survey Cohort to explore symptoms through different stages of menopause. Methods The KISO Survey targeted 575,863 women aged 45-59 living in Denmark. Data was collected via digital questionnaires from June to December 2024, covering stages of menopause based on STRAW + 10, menopausal symptoms using MRS, quality of life using UQOL, physical activity measured with IPAQ, work productivity loss based on WPAI, and various health, social and lifestyle factors. Statistical analyses were performed to assess symptom prevalence and severity across stages of menopause. Results A total of 153,800 women participated in the study (27% response rate), with 8% in premenopause, 24% in perimenopause, and 45% in postmenopause. Additionally, 13% had induced menopause and 10% were on menopausal hormone therapy (MHT). Symptom prevalence and severity increased notably from premenopause to perimenopause and continued to be present through postmenopausal phases. Women in early postmenopause (1-2 years) reported the highest total symptom burden with 24% experiencing severe symptoms, compared with women in other menopausal phases. While women with induced menopause and on MHT reported an even higher prevalence of severe symptoms (31% and 38%, respectively). Urogenital symptoms were the most severe symptom domain across all stages, peaking among women in late early postmenopause (>2-8 years), with 38% reporting these symptoms as severe. Implications This is the first study to provide large-scale data on menopausal symptoms among women in Denmark. The KISO Survey Cohort offers unique and extensive data, enabling future studies to advance our understanding of menopause and its impact on women. Key messages • Women in early postmenopause report the highest menopausal symptom burden, with 24% experiencing severe symptoms. • The KISO Survey Cohort offers unique data to advance our understanding of menopause.

European Journal of Public HealthVol. 35(Supplement_4)
University of Copenhagen (DK), Frederiksberg Hospital (DK), University College Copenhagen (DK)
Openalex Percentile: Top 59%
Sex and Gender in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.